Starry Pharma has secured nearly $40 million in Series B+ funding, with participation from investors including Hillhouse Ventures, LYFE Capital, and Lilly Asia Ventures. The capital will accelerate clinical development for its in vivo CAR-T therapies and expand its mRNA innovation efforts. Separately, Uncharted Dynamics, a company focused on embodied AI infrastructure, raised a seed round of several million dollars led by Summit Ascent, to fund R&D for its high-precision dynamics solver and North American expansion. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
IMPACT These funding rounds will advance AI infrastructure and therapeutic development, potentially accelerating innovation in embodied AI and cell-based treatments.
RANK_REASON The cluster contains two distinct funding rounds for AI-related companies, one of which is a significant amount for a Series B+ round. [lever_c_demoted from significant: ic=1 ai=0.7]